Literature DB >> 15359573

Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates.

Nabila Sekkat1, Yogeshvar N Kalia, Richard H Guy.   

Abstract

PURPOSE: The purpose of this study was (i) to validate differentially tape-stripped, porcine skin as an in vitro model for the evaluation of transdermal drug delivery (TDD) to premature neonates, (ii) to determine whether the model could estimate neonatal skin permeability as a function of postconceptional age (PCA), and (iii) to demonstrate that iontophoretic delivery permits precise control of drug input independent of skin barrier function.
METHODS: Passive permeation of caffeine, phenobarbital, and lidocaine across tape-stripped porcine skin barriers was measured. Iontophoretic delivery of lidocaine across skins with different barrier competencies was also evaluated.
RESULTS: For all drugs, passive permeation correlated with skin barrier function; that is, with transepidermal water loss (TEWL): Jss = A x exp[B x TEWL]. Combining this result with a previously derived dependence of TEWL upon the PCA of premature neonates in vivo allowed a relative value of Jss to be predicted for a given PCA. Comparison of these predictions showed excellent agreement with experimental data reported for diamorphine. Iontophoretic lidocaine delivery was precisely controllable independent of barrier competency.
CONCLUSIONS: Porcine skin, in vitro, differentially tape-stripped to specific barrier competencies, is a useful model to explore TDD in premature neonates. The potential for iontophoresis to provide improved dose control and adjustment, irrespective of skin barrier maturity, is established.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359573     DOI: 10.1023/b:pham.0000036912.94452.d0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis.

Authors:  K C Sung; J Y Fang; O Y Hu
Journal:  J Control Release       Date:  2000-06-15       Impact factor: 9.776

2.  Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss.

Authors:  N Sekkat; Y N Kalia; R H Guy
Journal:  J Pharm Sci       Date:  2004-12       Impact factor: 3.534

3.  The immature skin.

Authors:  N Rutter
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

4.  Transdermal delivery of theophylline to premature infants using a hydrogel disc system.

Authors:  R G Cartwright; P H Cartlidge; N Rutter; C D Melia; S S Davis
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

5.  In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species.

Authors:  N Kanikkannan; J Singh; P Ramarao
Journal:  J Control Release       Date:  2001-03-12       Impact factor: 9.776

6.  Characterization of the iontophoretic permselectivity properties of human and pig skin.

Authors:  D Marro; R H Guy; M B Delgado-Charro
Journal:  J Control Release       Date:  2001-01-29       Impact factor: 9.776

Review 7.  Transdermal delivery and the premature neonate.

Authors:  D A Barrett; N Rutter
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1994       Impact factor: 4.889

Review 8.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

9.  Percutaneous administration of theophylline in the preterm infant.

Authors:  N J Evans; N Rutter; J Hadgraft; G Parr
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

10.  Development of the epidermis in the newborn.

Authors:  N J Evans; N Rutter
Journal:  Biol Neonate       Date:  1986
View more
  6 in total

1.  Skin localization of cow's milk proteins delivered by a new ready-to-use atopy patch test.

Authors:  D Soury; G Barratt; S Ah-Leung; P Legrand; H Chacun; G Ponchel
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

2.  Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining.

Authors:  Wing Man Lau; Alex W White; Charles M Heard
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

Review 3.  [Special features of the skin in newborns and young infants].

Authors:  H Ott; P H Höger
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

Review 4.  Skin models for the testing of transdermal drugs.

Authors:  Eman Abd; Shereen A Yousef; Michael N Pastore; Krishna Telaprolu; Yousuf H Mohammed; Sarika Namjoshi; Jeffrey E Grice; Michael S Roberts
Journal:  Clin Pharmacol       Date:  2016-10-19

Review 5.  Transdermal Permeation of Drugs in Various Animal Species.

Authors:  Hiroaki Todo
Journal:  Pharmaceutics       Date:  2017-09-06       Impact factor: 6.321

6.  Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats.

Authors:  Advait V Badkar; Alan M Smith; Jonathan A Eppstein; Ajay K Banga
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.